← Back to KRYS

Krystal Biotech Inc. financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 03/08/2026Sep 2025Filed 03/11/2025Jun 2025Filed 03/08/2026Mar 2025Filed 03/08/2026Sep 2024Filed 03/11/2025Jun 2024Filed 03/11/2025Mar 2024Filed 03/11/2025
$119$116$98$96$88$84$70$45
$55$56$79$38$36$27$16$0.9
$1.79$1.83$2.66$1.29$1.20$0.91$0.53$0.03
3131303030303029

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.